Physician profile
Mark Jenson
NPI 1598727000
$204,420.98
in general payments reported to CMS, 2019-2025
65 companies · $41K in 2025
The $41K reported for 2025 was more than what 99% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $24K · 2020: $25K · 2021: $28K · 2022: $31K · 2023: $22K · 2024: $34K · 2025: $41K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $87K · Food and Beverage: $8,839 · Travel and Lodging: $1,133.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $87,080.85 |
| Food and Beverage | $8,839.47 |
| Travel and Lodging | $1,133.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $164,352.55 | 2020-2025 | Trintellix |
| Shire North American Group INC | $22,117.50 | 2019 | |
| Abbvie INC. | $1,769.08 | 2021-2025 | |
| Lilly USA, LLC | $1,532.43 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Amgen INC. | $1,222.57 | 2019-2025 | Repatha, Otezla, Otezla |
| Pfizer INC. | $1,130.12 | 2019-2025 | |
| Astrazeneca Pharmaceuticals Lp | $1,117.79 | 2019-2025 | Breztri, Airsupra, Lokelma |
| Novo Nordisk INC | $1,113.60 | 2019-2025 | Rybelsus, Ozempic, Wegovy |
| Otsuka America Pharmaceutical, INC. | $948.56 | 2021-2025 | Rexulti |
| Janssen Pharmaceuticals, INC | $764.73 | 2019-2024 | Xarelto |
| Boehringer Ingelheim Pharmaceuticals, INC. | $680.97 | 2019-2025 | Jardiance |
| Supernus Pharmaceuticals, INC. | $618.23 | 2021-2024 | Qelbree, Qelbree |
| Teva Pharmaceuticals USA, INC. | $414.64 | 2019-2025 | Austedo Xr, Austedo Xr, Ajovy |
| Allergan, INC. | $356.12 | 2019-2021 | |
| Gilead Sciences, INC. | $345.23 | 2021-2025 |
Show all 65 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Almatica Pharma LLC | $307.28 | 2022-2024 | Loreev Xr, Sertraline Hcl, Gralise |
| Ironshore Pharmaceuticals INC. | $289.44 | 2019-2023 | Jornay Pm |
| Merck Sharp & Dohme LLC | $284.65 | 2019-2023 | Vaxelis, Gardasil 9, Vaxneuvance |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $263.81 | 2023-2025 | Caplyta |
| Corium, LLC | $255.81 | 2022-2024 | Azstarys |
| Novartis Pharmaceuticals Corporation | $241.21 | 2019-2023 | |
| Tris Pharma INC | $203.42 | 2023-2025 | Dyanavel Xr, Quillichew Er, Quillivant |
| Bayer Healthcare Pharmaceuticals INC. | $202.87 | 2021-2023 | |
| Amarin Pharma, INC. | $191.59 | 2020-2022 | |
| Sumitomo Pharma America, INC. | $183.14 | 2024-2025 | Gemtesa |
| E.R. Squibb & Sons, L.L.C. | $181.86 | 2019-2025 | Eliquis |
| Sanofi-Aventis U.S. LLC | $167.34 | 2019-2021 | |
| Astellas Pharma US INC | $166.91 | 2019-2024 | Veozah, Myrbetriq |
| Abbott Laboratories | $166.02 | 2023-2025 | Freestyle Libre 3, Freestyle Libre 2, Freestyle Libre |
| Collegium Pharmaceutical, INC. | $164.47 | 2020-2025 | Jornay Pm |
| Acadia Pharmaceuticals INC | $162.02 | 2019-2023 | Nuplazid |
| Scilex Pharmaceuticals INC. | $156.95 | 2019-2023 | Ztlido |
| Biohaven Pharmaceutical Holding Company Ltd. | $148.24 | 2022 | |
| Lundbeck LLC | $141.25 | 2023-2025 | Rexulti, Vyepti |
| Esperion Therapeutics, INC. | $139.82 | 2020-2021 | |
| Axsome Therapeutics, INC. | $137.14 | 2024-2025 | Auvelity |
| Neurocrine Biosciences, INC. | $133.90 | 2024-2025 | Ingrezza |
| Biohaven Pharmaceuticals, INC. | $132.16 | 2020-2021 | |
| Pacira Therapeutics, INC. | $126.91 | 2020-2021 | |
| Lexicon Pharmaceuticals, INC. | $121.71 | 2023-2024 | Inpefa |
| Kowa Pharmaceuticals America, INC. | $112.77 | 2020-2021 | |
| Covis Pharma Gmbh | $99.59 | 2022-2023 | |
| Alkermes, INC. | $83.88 | 2023 | Aristada, Lybalvi |
| Exact Sciences Corporation | $80.38 | 2024-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Avanir Pharmaceuticals, INC. | $78.19 | 2019 | |
| Alexion Pharmaceuticals, INC. | $77.00 | 2023-2024 | Strensiq |
| Vanda Pharmaceuticals INC. | $74.85 | 2019-2025 | Fanapt |
| Glaxosmithkline, LLC. | $70.84 | 2019-2024 | Shingrix, Arexvy |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $70.62 | 2019 | |
| Mallinckrodt Hospital Products INC. | $66.09 | 2025 | Acthar |
| Sanofi Pasteur INC. | $58.74 | 2019-2023 | |
| Dexcom, INC. | $45.69 | 2021-2023 | Dexcom G6 Transmitter |
| Janssen Biotech, INC. | $43.33 | 2019 | |
| Neos Therapeutics, Lp | $42.95 | 2019-2020 | |
| Ironwood Pharmaceuticals, INC | $37.92 | 2020 | |
| Phathom Pharmaceuticals, INC. | $36.22 | 2024 | Voquezna |
| Bausch Health US, LLC | $32.74 | 2022 | |
| Electronic Waveform Lab, INC. | $24.79 | 2019-2020 | |
| Aimmune Therapeutics, INC. | $24.20 | 2024 | |
| Bioventus LLC | $23.32 | 2024 | Supartz Fx Sodium Hyaluronate |
| Ethicon US, LLC | $21.82 | 2022 | |
| Xeris Pharmaceuticals, INC. | $19.21 | 2023 | Gvoke Hypopen |
| Hologic Sales and Service, LLC | $14.38 | 2020 | |
| Eisai INC. | $14.16 | 2022 | |
| Tactile Systems Technology INC | $13.26 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Jenson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.